Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00759941 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 86
- Enrollment target
NCT00759941 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 86 participants.
The verdict
NCT00759941, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 86 participants
- Enrollment target
Study Summary
The purpose of this study was to assess the efficacy of adding Azopt dosed three times a day to Xalatan as compared to that of adding placebo to Xalatan in patients with elevated intraocular pressure.
Interventions
- DRUG Placebo eye drops
- DRUG Brinzolamide 1% ophthalmic solution (Azopt)
- DRUG Latanoprost 0.005% ophthalmic solution (Xalatan)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00759941
The ClinicalTrials.gov registry entry for NCT00759941 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo eye drops is the first listed.
NCT00759941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00759941 about?
NCT00759941 is a clinical study titled "A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin". The purpose of this study was to assess the efficacy of adding Azopt dosed three times a day to Xalatan as compared to that of adding placebo to Xalatan in patients with elevated intraocular pressure.
What is the current status of trial NCT00759941?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 86 participants. The study started on 2007-10. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00759941?
The interventions under investigation include: Placebo eye drops (DRUG), Brinzolamide 1% ophthalmic solution (Azopt) (DRUG), Latanoprost 0.005% ophthalmic solution (Xalatan) (DRUG).
Who is sponsoring clinical trial NCT00759941?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.